Radio and PodcastLive Radio & Podcasts
Science & Medicine
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer
Editor’s Choice: Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consort...
About This Episode
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer is an episode from Gynecologic Oncology by Health Advance. Editor’s Choice: Platinum-free interval and response to platinum retreatment or lenvatinib/pembrol...
Podcast
This episode belongs to Gynecologic Oncology.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Mar 26, 2025, 16:12 long, audio available.
Related Episodes
Continue listening to more episodes from Gynecologic Oncology.
PARP Inhibitors in Ovarian Cancer: A Society of Gynecologic Oncology Podcast
May 8, 2026 - 19:50
Home the Same Day? Testing the Limits in Ovarian Cancer Debulking Surgery
Apr 8, 2026 - 18:21
Recognizing and Managing ADC-Associated Pulmonary Toxicities
Mar 16, 2026 - 29:40
In good SHAPE
Feb 1, 2026 - 23:45
ctDNA-Guided PARPi Therapy in Ovarian Cancer
Jan 1, 2026 - 25:21
Beyond treatment: The who, why, when, where and what of cancer follow up
Dec 1, 2025 - 28:29
Ovarian Cancer After Breast Cancer in Women with BRCA Variants
Nov 20, 2025 - 28:31